Issues
-
Cover Image
Cover Image
SMARCA4/BRG1 mutations account for 10%-15% of lung cancers. DNA fibers provide a microscopic foray into the realm of ongoing DNA replication events, demonstrating that loss of BRG1 promotes tumor progression not through over proliferation but via changes at replication forks due to increased firing of replication origins, contributing to fork stress and genome instability in lung cancers. For details, see article by Gupta and colleagues on page 3841. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
Cancer Research
Table of Contents
Breaking Insights
Obituary
Reviews
Cancer Research Highlights
Controversy and Consensus
Genome and Epigenome
The D2 and D3 Sublineages of Human Papilloma Virus 16–Positive Cervical Cancer in Guatemala Differ in Integration Rate and Age of Diagnosis
Accumulation of Molecular Aberrations Distinctive to Hepatocellular Carcinoma Progression
Metabolism and Chemical Biology
Molecular Cell Biology
BRG1 Loss Predisposes Lung Cancers to Replicative Stress and ATR Dependency
RAD51AP1 Deficiency Reduces Tumor Growth by Targeting Stem Cell Self-Renewal
Tumor Biology and Immunology
Interaction with CD68 and Regulation of GAS6 Expression by Endosialin in Fibroblasts Drives Recruitment and Polarization of Macrophages in Hepatocellular Carcinoma
P2X7 Receptor Activity Limits Accumulation of T Cells within Tumors
IL6 Fuels Durable Memory for Th17 Cell–Mediated Responses to Tumors
A Genetic Vaccine Encoding Shared Cancer Neoantigens to Treat Tumors with Microsatellite Instability
Convergence and Technologies
MRI Distinguishes Tumor Hypoxia Levels of Different Prognostic and Biological Significance in Cervical Cancer
Population and Prevention Science
Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk
Correction
Journal Archive
Cancer Research
(1941-Present; volumes 1-current)Published twice monthly since 1987. From 1941-1986, published monthly.
(ISSN 0008-5472)
The American Journal of Cancer
(1931-1940; volumes 15-40)Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.
(ISSN 0099-7374)
The Journal of Cancer Research
(1916-1930); volumes 1-14)Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.
(ISSN 0099-7013)
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.